Skip to content
MarketScale
‹ Back to IndustriesHealthcare

How to Use Speed and Accuracy to Practice Quality Medical Reporting

A recent study published in the Journal of the American Board of Family Medicine found that, as it relates to reporting cardiovascular disease quality measures, smaller practices not affiliated with a larger organization and without centralized quality improvement support reported clinical quality measures more efficiently. While there was no difference in the final outcome and 91% of…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Start free

recent study published in the Journal of the American Board of Family Medicine found that, as it relates to reporting cardiovascular disease quality measures, smaller practices not affiliated with a larger organization and without centralized quality improvement support reported clinical quality measures more efficiently.

While there was no difference in the final outcome and 91% of practices studied had submitted data over a 15-month period, smaller practices submitted more data early on in the study than their affiliated counterparts.

Regardless of speed, practices of all sizes, even those managed by larger affiliates, can benefit in addressing quality reporting by engaging in the use of an Electronic Health Record (EHR) solution.

In fact, a third-party service could potentially help these larger organizations untangle some of the lengthy reporting queues generated by their sheer size.

Reporting Requirements

The United States Centers for Medicare & Medicaid Services outlines certain electronic clinical quality measures, or eCQMs, that “help measure and track the quality of health care services that eligible professionals, eligible hospitals, and critical access hospitals provide.”

Reporting these eCQMs helps measure many aspects of care, including:

  • Patient and Family Engagement
  • Patient Safety
  • Care Coordination
  • Population/Public Health
  • Efficient Use of Healthcare Resources
  • Clinical Process/Effectiveness

Reporting is critical to participation in CMS programs, but also helps ensure the care practices are providing is timely, effective, safe and more. In other words, eCQM reporting and other forms of quality measurement reporting help practices ensure they’re meeting their No. 1 goal – serving patients.

EHR solutions provide key data to help facilitate reporting of quality measures, and leveraging a third-party solution can help practices streamline their own practice quality reporting.

The Advantages of Certified EHR Technology in Boosting Reporting Efficiency

When practices leverage a certified EHR solution to engage in quality reporting, the benefits can be immediate and measurable.

They include:

  • Workload reduction and the ability to allow staff to focus on other critical tasks
  • Potential automation of data capture and calculation and report generation
  • Potential bonuses for reporting electronically
  • Integration with a more holistic approach to efficiency provided by a certified EHR

Choosing ChartLogic

ChartLogic’s EHR solution is an industry leader, helping develop unique answers to the challenges practices of all sizes face in delivering elevated patient outcomes.

ChartLogic also offers helping reporting consultation in the form of MIPS Consulting, helping practices understand how to get the most of MIPS reporting and bonuses.

To learn more, schedule a demo today.

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free plan

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale workspace, up to 10 people
One professional video edit a month for qualifying companies
Media requests to your crowd, remote recording, AI writing tools
$0, no credit card, nothing that expires

More Healthcare Insights

NICE recommends Enhertu for HER2-low advanced breast cancer in England

NICE recommends Enhertu for HER2-low advanced breast cancer in England

American Pharmaceutical Review reported that NICE has recommended Enhertu for routine NHS use in people with HER2-low advanced breast cancer, following a commercial agreement and updates to NICE’s methods under the U.K.-U.S. Pharmaceutical Pricing Agreement.

  • 01NICE tied the reversal to 2026 changes: higher cost-effectiveness thresholds that took effect in April and a new quality-of-life assessment method published Aug. 27, 2026.
  • 02Access planning still varies by nation: Fierce Pharma reported Wales requires funding within 60 days of final guidance, while Scotland and Northern Ireland follow separate processes.

Sep 21, 2026

Eli Lilly’s $6.5B Houston Bet Highlights U.S. Pharma Reshoring

Eli Lilly’s $6.5B Houston Bet Highlights U.S. Pharma Reshoring

Eli Lilly has broken ground on a $6.5 billion manufacturing facility in Houston, slated for completion around 2030. While attention has focused on scaling production of Foundayo, its oral GLP-1 treatment, the project also reflects broader U.S. efforts to rebuild domestic pharmaceutical manufacturing and highlights the supply chain challenge of forecasting demand and building capacity years in advance.

  • 01Eli Lilly commits $6.5 billion to a Houston pharmaceutical manufacturing facility due for completion around 2030, one of the largest single U.S. pharma production investments in recent years
  • 02GLP-1 demand forecasting remains highly uncertain, making it difficult to commit billions to manufacturing capacity years before demand and required output are clear.
  • 03Houston's selection reflects industrial capacity and workforce depth, positioning the region as a biomanufacturing corridor and creating long-term hiring demand in engineering, quality control, and skilled trades

Sep 21, 2026

NextGen Invent’s Deepak Mittal argues for scoped healthcare AI pilots with early governance

NextGen Invent’s Deepak Mittal argues that healthcare AI pilots can begin with a reliable data subset and early governance. His performance figures are vendor claims, not independently verified results.

  • 01Deepak Mittal advocates starting with a defined problem and suitable data rather than waiting for perfect organization-wide data.
  • 02Some performance figures cited in the interview (for example, preparation time and model counts) are company-reported and not independently verified in this article.
  • 03NIST’s voluntary AI Risk Management Framework provides an independent structure for governance and risk evaluation.

Sep 21, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512